Literature DB >> 33860573

Design of experiments for development and optimization of a liquid chromatography coupled to tandem mass spectrometry bioanalytical assay.

Unnur Arna Thorsteinsdóttir1,2, Margrét Thorsteinsdóttir1,2.   

Abstract

Design of experiments (DoE) is a valuable tool for optimization of a quantitative bioanalytical method utilizing liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Liquid chromatography mass spectrometry (LC-MS) is composed of several processes, including, liquid introduction and analyte ionization. The goal is to transfer analytes from atmospheric pressure to vacuum and maintain conditions that are compatible for both the LC and the MS. These processes involve many experimental factors which need to be simultaneously optimized to obtain maximum sensitivity and resolution at minimum retention time. In this tutorial the basic concepts of DoE will be explained with focus on practical use of DoE, and then three case studies about utilization of DoE for optimization of liquid chromatography tandem mass spectrometry (LC-MS/MS) quantitative assays will be presented.
© 2021 John Wiley & Sons, Ltd.

Keywords:  D-optimal design; bioanalysis; clinical mass spectrometry; design of experiments (DoE); response surface methodology; tutorial

Year:  2021        PMID: 33860573     DOI: 10.1002/jms.4727

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  2 in total

1.  Chromatography Conditions Development by Design of Experiments for the Chemotype Differentiation of Four Bauhinia Species.

Authors:  Amanda J Aquino; Edenir R Pereira-Filho; Regina V Oliveira; Quezia B Cass
Journal:  Front Chem       Date:  2022-05-23       Impact factor: 5.545

2.  Quality by Design Assisted Optimization of a Chiral Capillary Electrokinetic Chromatographic Method for the Separation of Amlodipine Enantiomers Using Maltodextrin as Chiral Selector.

Authors:  Ratih Ratih; Hermann Wätzig; Matthias Oliver Stein; Sami El Deeb
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.